Clinical trial

Sunitinib Treatment on Tissue Sodium Accumulation (TSS2)

NCT04368546

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2015-11-01

PhaseN/A

Study timeline

Study start (actual)2015-11-01Date precision: day

Registry last updated2021-01-27

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Renal Cell Cancer Metastaticunresolved

Hypertensionunresolved

Sodium Imbalanceunresolved

Interventions

SunitinibDRUG · verified · RxNorm: sunitinib

Sponsors & collaborators

Charite University, Berlin, Germanylead sponsor

German Heart Institutecollaborator

Mapped research locations

BerlinGermany1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04368546 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.